IPP Bureau
Proexp Pharma collaborates with Carbanio
By IPP Bureau - June 02, 2022
As per partnership, Carbanio will arrange raw materials and other custom chemicals for Proexp Pharma Pvt. Ltd. through an uninterrupted digital process of the company
BGS Gleneagles launches its refurbished advanced emergency & trauma center
By IPP Bureau - June 02, 2022
120+ members of multi-disciplinary medical team are trained to provide seamless, outcome driven trauma and emergency care
PMBI first time ever crossed Rs. 100 crore sales in May, 2022
By IPP Bureau - June 02, 2022
Govt. has set a target to increase the number of JanAushadhi Kendras to 10,000 by March 2024
Govt. launches 2-months long ‘Har Ghar Dastak 2.0’ campaign to expedite Covid-19 vaccination coverage
By IPP Bureau - June 02, 2022
Focussed campaigns for old age homes, schools/colleges, prisons, brick kilns to be taken up by States/UTs
DuPont opens new biopharma tubing manufacturing site in US
By IPP Bureau - June 02, 2022
The site, located in Berkeley County, will be operated using the same quality standards as DuPont’s Healthcare Industries Materials Site, the company’s longstanding biopharmaceutical manufacturing site in Hemlock, Michigan
Cipla adds capacity of captive renewable energy power plant in Maharashtra & Karnataka
By IPP Bureau - June 02, 2022
By 2025, Cipla plans to achieve carbon and water neutrality, zero-waste to landfill, anti-microbial resistance stewardship and green chemistry.
Moderna to become marketing authorization holder in Japan for Spikevax
By IPP Bureau - June 01, 2022
Companies concluded memorandum of understanding that Takeda will continue to provide distribution support for the Moderna COVID-19 vaccines for a transitional period
ENTOD Pharmaceuticals gets DCGI nod to carry out the phase 3 trials of 0.05% atropine eye drops
By IPP Bureau - June 01, 2022
Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children
PAYBACK India announces a strategic partnership with Apollo Pharmacy
By IPP Bureau - June 01, 2022
PAYBACK loyalty will be live in 4500 Apollo Pharmacy outlets across India
Ayu Health Hospitals announces t expansion plan in Rajasthan
By IPP Bureau - June 01, 2022
This expansion announcement came right after raising series B funding of $27 Mn in a round led by Fundamentum Partnership, earlier this month.
USFDA accepts dupilumab for priority review in adults with prurigo nodularis
By IPP Bureau - June 01, 2022
Dupixent would be the first and only medicine specifically indicated to treat prurigo nodularis in the U.S., if approved
FDA approves Roche’s Evrysdi for use in babies under two months with SMA
By IPP Bureau - June 01, 2022
Evrysdi has proven efficacy in babies, children and adults with more than 5,000 patients treated to date
Tetra Bio-Pharma appoints CFO
By IPP Bureau - June 01, 2022
Auld is a seasoned Financial Executive with over 30 years of relevant experience
US FDA accepts new drug application filed by Avillion for AstraZeneca's PT027
By IPP Bureau - June 01, 2022
Avillion announces expansion of partnership with AstraZeneca on PT027 and will fund and execute a new Phase 3b study
